Bharat Book Bureau
US market to rise 9.8% per year to $23 billion in 2012. Orthopedic implant demand is forecast to rise 9.8 percent annually to $23 billion in 2012. The four major product segments -- reconstructive joint replacements, spinal implants, orthobiologics and trauma implants -- will all provide strong growth opportunities. The market for reconstructive joint replacements will gain upward momentum from an aging population and the widespread prevalence of physically active lifestyles, thereby expanding the number of persons suffering from injured and deteriorating joints.
Knees, hips remain leading joints for replacement
Knees and hips are highly vulnerable to degeneration caused by arthritic conditions, and will continue to account for the majority of reconstructive joint replacements. Continuing advances in materials and design will improve the safety and performance features of knee and hip implants and encourage their expanding use in severe arthritis treatment. Among other reconstructive joint replacements, total and partial shoulder systems will post the strongest demand and realize the best growth prospects based on advantages over alternative therapies in the reduction of pain and restoration of mobility. Advances in product technologies and related surgical techniques, coupled with an increasing prevalence of chronic back conditions, will create strong growth opportunities for spinal implants. Implants used in spinal fusion and motion preservation surgeries, especially procedures for the repair of vertebrae and replacement of degenerative discs, will account for the largest market share and the best growth opportunities. Due to outcome advantages over alternative drug and physical therapies, surgery is emerging as the preferred treatment option for many spinal cord injuries and abnormalities. This trend reflects the increasing availability of high value-added devices such as fusion cages and artificial discs.
Orthobiologic products to post the strongest gains
Orthobiologics will post the best gains among all orthopedic implants. Growth factors, grafts and synthetic materials for the replacement and fortification of diseased and damaged bone are among orthobiologics expected to fare especially well in the marketplace, benefitting from new product introductions and expanding applications in the support of spinal and trauma procedures. Viscosupplementation substances, bone cement, and artificial tissue implants are also well-positioned to capture strong growth in demand. Ongoing formulation improvements will keep bone cement a leading material used in reconstructive joint replacements and spinal implants. Viscosupplementation substances, primarily hyaluronic acid preparations, will exhibit strong growth opportunities as an alternative to reconstructive implants in the treatment of knees afflicted with mild to moderate forms of osteoarthritis. Bioengineered tissue implants will be leading materials for the repair and reconstruction of injured knees, elbows and shoulders, especially in sports medicine applications. An anticipated increase in the number of fracture injuries attributable to demographic and lifestyle trends will stimulate demand for trauma fixation implants. The best growth prospects will emerge in anatomically shaped plating systems for complex fractures near joints and intramedullary nails for long bone fractures. Resorbable plates and screws for craniomaxillofacial procedures will also post strong gains in demand as they eliminate the need for secondary, removal surgery.
Study coverage
Orthopedic Implants is a new industry study priced at $4500. It presents historical demand data (1997, 2002 and 2007) plus forecasts for 2012 and 2017 by product type and market.This study also assesses key US market environment factors, evaluates company market shares and profiles major industry competitors.
For more information, please visit:
http://www.bharatbook.com/
Photo:
http://www.prlog.org/
